The Medical Device Business Journal — Medical Device News & Articles | MassDevice
MASSDEVICE ON CALL — Alleged Biotronik chicanery prompts calls for feds: German cardiac device maker Biotronik is under the spotlight in Nevada after a New York Times probe of a Las Vegas hospital’s allegedly purchased preference for the company’s pacemakers and defibrillators.
Medtronic Inc. (NYSE:MDT) said results from the Improve HF study demonstrate that select guideline-based outpatient heart failure measures can increase patient survival and might be useful for improving patient quality of care.
The Improve HF (The Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting) study is the largest U.S.-based outpatient heart failure clinical study. The results of the study were published in the journal Circulation.
